148 related articles for article (PubMed ID: 19034021)
1. Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation.
Neff RT; Hurst FP; Falta EM; Bohen EM; Lentine KL; Dharnidharka VR; Agodoa LY; Jindal RM; Yuan CM; Abbott KC
Transplantation; 2008 Nov; 86(10):1474-8. PubMed ID: 19034021
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil associated with progressive multifocal leukoencephalopathy with successful outcome.
El Kabbaj D; Hassani M; Kadiri M; Mounach J; Ouhabi H; Haimeur C; Oualim Z
Saudi J Kidney Dis Transpl; 2012 Jul; 23(4):790-3. PubMed ID: 22805393
[TBL] [Abstract][Full Text] [Related]
3. Polyoma virus-associated progressive multifocal leukoencephalopathy after renal transplantation: regression following withdrawal of mycophenolate mofetil.
Weber SC; Uhlenberg B; Raile K; Querfeld U; Müller D
Pediatr Transplant; 2011 Mar; 15(2):E19-24. PubMed ID: 20880091
[TBL] [Abstract][Full Text] [Related]
4. The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients.
Flechner SM; Zhou L; Derweesh I; Mastroianni B; Savas K; Goldfarb D; Modlin CS; Krishnamurthi V; Novick A
Transplantation; 2003 Dec; 76(12):1729-34. PubMed ID: 14688524
[TBL] [Abstract][Full Text] [Related]
5. Hypogammaglobulinemia and bronchiectasis in mycophenolate mofetil-treated renal transplant recipients: an emerging clinical phenomenon?
Boddana P; Webb LH; Unsworth J; Brealey M; Bingham C; Harper SJ
Clin Transplant; 2011; 25(3):417-9. PubMed ID: 20438577
[TBL] [Abstract][Full Text] [Related]
6. Does mycophenolate mofetil increase the incidence of infections in stable renal transplant recipients initially treated with a two-drug regimen?
Chen Y; Chu SH; Wei TY; Yen TH; Chiang YJ; Wu CT; Chen HW
Transplant Proc; 2004 Sep; 36(7):2122-3. PubMed ID: 15518769
[TBL] [Abstract][Full Text] [Related]
7. Good outcome of brain stem progressive multifocal leukoencephalopathy in an immunosuppressed renal transplant patient: Importance of early detection and rapid immune reconstitution.
Sauer R; Gölitz P; Jacobi J; Schwab S; Linker RA; Lee DH
J Neurol Sci; 2017 Apr; 375():76-79. PubMed ID: 28320193
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil.
Hardinger KL; Brennan DC; Lowell J; Schnitzler MA
Transpl Int; 2004 Nov; 17(10):609-16. PubMed ID: 15517170
[TBL] [Abstract][Full Text] [Related]
9. Comparing outcomes associated with dose manipulations of enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients.
Cooper M; Deering KL; Slakey DP; Harshaw Q; Arcona S; McCann EL; Rasetto FA; Florman SS
Transplantation; 2009 Aug; 88(4):514-20. PubMed ID: 19696634
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil versus enteric-coated mycophenolate sodium: a large, single-center comparison of dose adjustments and outcomes in kidney transplant recipients.
Sollinger HW; Sundberg AK; Leverson G; Voss BJ; Pirsch JD
Transplantation; 2010 Feb; 89(4):446-51. PubMed ID: 20177347
[TBL] [Abstract][Full Text] [Related]
11. Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation?
Basic-Jukic N; Kes P; Bubic-Filipi LJ; Puretic Z; Brunetta B; Pasini J
Transplant Proc; 2005 Mar; 37(2):850-1. PubMed ID: 15848553
[TBL] [Abstract][Full Text] [Related]
12. The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal transplantation.
Satoh S; Tada H; Murakami M; Tsuchiya N; Inoue T; Togashi H; Matsuura S; Hayase Y; Suzuki T; Habuchi T
Transplant Proc; 2005 May; 37(4):1751-3. PubMed ID: 15919454
[TBL] [Abstract][Full Text] [Related]
13. Progressive multifocal leukoencephalopathy 11 years after liver transplantation: a case report.
Moreno-Estébanez A; Almeida Velasco J; Pérez-Concha T; González-Pinto T; Gabilondo I
J Neurovirol; 2017 Dec; 23(6):929-931. PubMed ID: 28900866
[TBL] [Abstract][Full Text] [Related]
14. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
15. Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients.
Budde K; Glander P; Diekmann F; Dragun D; Waiser J; Fritsche L; Neumayer HH
Transplant Proc; 2004 Mar; 36(2 Suppl):524S-527S. PubMed ID: 15041401
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
[TBL] [Abstract][Full Text] [Related]
17. Progressive multifocal leukoencephalopathy associated with mycophenolate mofetil treatment in a woman with lupus and CD4+ T-lymphocyte deficiency.
Pavlovic AM; Bonaci-Nikolic B; Kozic D; Ostojic J; Abinun M; Svabic-Medjedovic T; Nikolic M; Sternic N
Lupus; 2012 Jan; 21(1):100-2. PubMed ID: 21976399
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure.
Bunnapradist S; Lentine KL; Burroughs TE; Pinsky BW; Hardinger KL; Brennan DC; Schnitzler MA
Transplantation; 2006 Jul; 82(1):102-7. PubMed ID: 16861948
[TBL] [Abstract][Full Text] [Related]
19. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids.
Bunnapradist S; Daswani A; Takemoto SK
Transplantation; 2003 Jul; 76(1):10-5. PubMed ID: 12865780
[TBL] [Abstract][Full Text] [Related]
20. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
